Amy Schulman

Amy Schulman

Vermögen: 7 Mio $ am 31.05.2026

65 Jahre
Health Technology
Commercial Services
Health Services

Profil

Amy L.
Schulman
founded Lyndra Therapeutics, Inc. in 2015, where she is working as Executive Chairman from 2019 and LS Polaris Innovation Fund in 2017, where she is working as Managing Partner from 2017.
Ms. Schulman also founded Suono Bio, Inc., where she worked as Executive Chairman.
Ms. Schulman also currently works at SQZ Biotechnologies Co., as Chairman from 2015, Alnylam Pharmaceuticals, Inc., as Chairman from 2023, Elevance Health, Inc., as Independent Director from 2026, and various other companies.
Ms. Schulman also formerly worked at Eagle Biologics, Inc., as Chief Executive Officer from 2014 to 2016, Olivo Laboratories LLC, as Executive Chairman & Chief Executive Officer, Fractyl Health, Inc., as Independent Director from 2018 to 2025, and various other companies.
Ms. Schulman received her undergraduate degree from Wesleyan University and graduate degree in 1989 from Yale Law School.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
20.05.2026 23.211 ( 0,02 % ) 7 Mio $ 31.05.2026
13.05.2026 781 ( 0 % ) 307 081 $ 31.05.2026

Aktive Positionen von Amy Schulman

UnternehmenPositionBeginn
ALNYLAM PHARMACEUTICALS, INC. Vorsitzender 05.01.2023
SQZ BIOTECHNOLOGIES COMPANY Vorsitzender 01.07.2015
HUDSON EXECUTIVE INVESTMENT CORP. II Direktor/Vorstandsmitglied 25.01.2021
ELEVANCE HEALTH, INC. Direktor/Vorstandsmitglied 12.01.2026
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied 20.11.2019
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied -
░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ -
░░░░░░░ ░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ -
░░░░░░░░░ ░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ -
░░░░ ░░░░░░░░░░░░ ░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ -

Ehemalige bekannte Positionen von Amy Schulman

UnternehmenPositionEnde
░░░░░░░ ░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von Amy Schulman im Detail an

Ausbildung von Amy Schulman

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

71

Beziehungen ersten Grades

45

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen45

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Commercial Services

Health Technology

Producer Manufacturing

Health Technology

Health Services

Commercial Services

Consumer Services

Commercial Services

Health Services

Consumer Services

Commercial Services

Commercial Services

Commercial Services

Consumer Services

Health Technology

Consumer Non-Durables

Consumer Services

Health Technology

Consumer Non-Durables

Health Technology

Health Technology

Technology Services

Health Services

Health Technology

Health Technology

Technology Services

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Non-Durables

Health Technology

Health Technology

Finance

Health Services

Health Technology

Finance

Health Technology

  1. Börse
  2. Insiders
  3. Amy Schulman